首页> 外文期刊>Journal of neurotrauma >Dual Therapeutic Effects of C-10068, a Dextromethorphan Derivative, Against Post-Traumatic Nonconvulsive Seizures and Neuroinflammation in a Rat Model of Penetrating Ballistic-Like Brain Injury
【24h】

Dual Therapeutic Effects of C-10068, a Dextromethorphan Derivative, Against Post-Traumatic Nonconvulsive Seizures and Neuroinflammation in a Rat Model of Penetrating Ballistic-Like Brain Injury

机译:右美沙芬衍生物C-10068对穿透性弹道样脑损伤大鼠模型的创伤性非惊厥性癫痫发作和神经炎症的双重治疗作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Post-traumatic seizures can exacerbate injurious outcomes of severe brain trauma, yet effective treatments are limited owing to the complexity of the pathology underlying the concomitant occurrence of both events. In this study, we tested C-10068, a novel deuterium-containing analog of (+)-N-methyl-3-ethoxymorphinan, in a rat model of penetrating ballistic-like brain injury (PBBI) and evaluated the effects of C-10068 on PBBI-induced nonconvulsive seizures (NCS), acute neuroinflammation, and neurofunctional outcomes. NCS were detected by electroencephalographic monitoring. Neuroinflammation was evaluated by immunohistochemical markers, for example, glial fibrillary acidic protein and major histocompatibility complex class I, for activation of astrocytes and microglia, respectively. Neurofunction was tested using rotarod and Morris water maze tasks. Three infusion doses of C-10068 (1.0, 2.5, and 5.0mg/kg/hx72h) were tested in the antiseizure study. Neuroinflammation and neurofunction were evaluated in animals treated with 5.0mg/kg/hx72h C-10068. Compared to vehicle treatment, C-10068 dose dependently reduced PBBI-induced NCS incidence (40-50%), frequency (20-70%), and duration (30-82%). The most effective antiseizure dose of C-10068 (5.0mg/kg/hx72h) also significantly attenuated hippocampal astrocyte activation and perilesional microglial reactivity post-PBBI. Within C-10068-treated animals, a positive correlation was observed in reduction in NCS frequency and reduction in hippocampal astrocyte activation. Further, C-10068 treatment significantly attenuated astrocyte activation in seizure-free animals. However, C-10068 failed to improve PBBI-induced motor and cognitive functions with the dosing regimen used in this study. Overall, the results indicating that C-10068 exerts both potent antiseizure and antiinflammatory effects are promising and warrant further investigation.
机译:创伤后癫痫发作可加重严重脑损伤的伤害性后果,但由于两种事件同时发生的病理学复杂性,有效治疗受到限制。在这项研究中,我们在穿透弹道样脑损伤(PBBI)的大鼠模型中测试了C-10068(一种新型的含氘的(+)-N-甲基-3-乙氧基吗啡喃类似物),并评估了C- PBBI引起的非惊厥性癫痫发作(NCS),急性神经炎症和神经功能预后评估为10068。通过脑电图监测发现NCS。通过免疫组织化学标记物,例如神经胶质纤维酸性蛋白和主要的组织相容性复合物I类,评估星形胶质细胞和小胶质细胞的激活情况。使用旋转脚架和莫里斯水迷宫任务测试了神经功能。在抗癫痫研究中测试了三种输注剂量的C-10068(1.0、2.5和5.0mg / kg / hx72h)。在用5.0mg / kg / hx72h C-10068处理的动物中评估了神经炎症和神经功能。与媒介物治疗相比,C-10068剂量依赖性地降低了PBBI诱导的NCS发生率(40-50%),频率(20-70%)和持续时间(30-82%)。最有效的抗癫痫剂量C-10068(5.0mg / kg / hx72h)也显着减弱了PBBI后海马星形胶质细胞的活化和周围小胶质细胞的反应性。在用C-10068处理的动物中,观察到NCS频率减少和海马星形胶质细胞激活减少呈正相关。此外,C-10068处理可显着减弱无癫痫动物的星形胶质细胞活化。然而,在本研究中使用的给药方案,C-10068无法改善PBBI诱导的运动和认知功能。总体而言,表明C-10068发挥有效的抗癫痫作用和抗炎作用的结果是有希望的,值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号